Below are the top diagnostic substances stocks on the NASDAQ in terms of operating margin.
The trailing-twelve-month operating margin at SurModics, Inc. SRDX is 33.60 percent. SurModics' PEG ratio is 2.06.
The trailing-twelve-month operating margin at Meridian Bioscience, Inc. VIVO is 27.60 percent. Meridian Bioscience's revenue for the same period is $193.50 million.
The trailing-twelve-month operating margin at AMAG Pharmaceuticals, Inc. AMAG is 22.30 percent. AMAG Pharmaceuticals' EPS for the same period is $4.40.
The trailing-twelve-month operating margin at Neogen Corporation NEOG is 18.20 percent. Neogen's ROE for the same period is 9.80 percent.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in